Hoechst/Andrx Cardizem CD Settlement is Pro-Competitive - Andrx
Executive Summary
The September 1997 generic Cardizem CD agreement between Andrx and Hoechst Marion Roussel is pro-competitive because it allows for the launch of a generic once-daily diltiazem regardless of the outcome of the patent suit between the two firms, Andrx maintained in response to class action suits.
You may also be interested in...
Aventis/Andrx Cardizem CD Deal Violated Antitrust Laws, Judge Says
Andrx and Aventis violated federal antitrust laws by entering an agreement aimed to keep all generic Cardizem CD products off the market, a June 6 Detroit federal court summary judgement maintains.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011